Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2023

MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present at Upcoming H.C. Wainwright Conference

Posted on September 7, 2023 by MissionIR

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced that its CFO Ryan Confer will be providing an overview of the company’s pioneering gene therapies for cancer and … Continue reading →

Posted in Genprex Inc. GNPX | Leave a comment

MissionIRNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Acquires High Times Intellectual Property, Featured in Financial News Media Article

Posted on September 7, 2023 by MissionIR

Lucy Scientific Discovery (NASDAQ: LSDI) today announced the acquisition of the intellectual property (“IP”) of High Times, an iconic brand in the cannabis industry. In addition to the Hightimes.com domain, the transaction also includes the trademarks for the Cannabis Cup … Continue reading →

Posted in Lucy Scientific Discovery Inc. LSDI | Leave a comment

MissionIRNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Releases First ESG Report

Posted on September 7, 2023 by MissionIR

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF), a company that is advancing the next generation of nickel-sulphide projects, has published its first-ever environmental, social and governance report. CNIKF’s 2022 Environmental, Social and Governance report contains key disclosures that the company is … Continue reading →

Posted in Canada Nickel Company Inc. CNIKF | Leave a comment

MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Featured in The New Stack Article Discussing Potential Impact of Quantum Computing on AI

Posted on September 7, 2023 by MissionIR

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, was spotlighted in a recent article from The New Stack titled “D-Wave Suggests Quantum Annealing Could Help AI.” The article notes that the effect of quantum computing … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Demonstrates Power of REE Processing During US Embassy Staff Visit to Kingston Plant

Posted on September 7, 2023 by MissionIR

Critical tech metal supply chain innovator Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) recently welcomed U.S. Embassy staff members on a tour of the company’s test demonstration facility in Ontario, showcasing the strategic international importance of Ucore’s rare earth element … Continue reading →

Posted in Ucore Rare Metals Inc. UURAF | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) Announces Update to Constrained Quadratic Model Hybrid Solver

Posted on September 7, 2023 by MissionIR

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, recently announced an update to its Constrained Quadratic Model (“CQM”) hybrid solver in its Leap(TM) quantum cloud service. … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

The Strategic Brilliance of Acquiring High Times IP, Including Existing Licensing Agreements and Royalty Streams in All-Stock Transaction

Posted on September 7, 2023 by MissionIR

Lucy Scientific Beats MindMed and Seelos Therapeutics to the Punch Lucy Scientific Discovery (NASDAQ: LSDI) (“Lucy” or the “Company), a Nasdaq-listed company with holdings and operations in a variety of psychotropic businesses, just announced the acquisition of the Intellectual Property … Continue reading →

Posted in Lucy Scientific Discovery Inc. LSDI | Leave a comment

MissionIRNewsBreaks – Why RVL Pharmaceuticals plc (NASDAQ: RVLP) Is ‘One to Watch’

Posted on September 6, 2023 by MissionIR

RVL Pharmaceuticals (NASDAQ: RVLP) is a specialty pharmaceutical company focusing on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution), 0.1%, available by prescription for the treatment of acquired blepharoptosis (low-lying eyelid(s)) in adults. “UPNEEQ(R) (‘RVL-1201’) is the first non-surgical treatment … Continue reading →

Posted in RVL Pharmaceuticals plc. RVLP | Leave a comment

MissionIRNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Releases Status Update on Company Activities

Posted on September 6, 2023 by MissionIR

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF), a company that is advancing the next generation of nickel-sulphide projects, has released an update regarding recent activities. The update noted new management announcements as well as a $12 million loan facility. According to … Continue reading →

Posted in Canada Nickel Company Inc. CNIKF | Leave a comment

MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Rebrands as Scinai Immunotherapeutics Ltd.

Posted on September 6, 2023 by MissionIR

BiondVax (NASDAQ: BVXV), a biotechnology company, today announced a change of its corporate name to Scinai Immunotherapeutics, which will debut on the Nasdaq under a new symbol, SCNI, on Sept. 7, 2023. In the past two years, the company has … Continue reading →

Posted in BiondVax Pharmaceuticals Ltd. BVXV | Leave a comment